Entos Pharmaceuticals

Activity by year

20252026

Investment

Mar 11, 2025INVESTMENTEdmonton, Alberta, Canada$138.0M90 jobs
Entos Pharmaceuticals receives $62M Canadian government grant for biomanufacturing facility
The Government of Canada announced a $62 million contribution to support Entos Pharmaceuticals' $198.5 million project to build a 103,000-square-foot biomanufacturing and R&D facility in Edmonton, Alberta. The facility will produce genetic medicines.
Entos Pharmaceuticals Government of Canada investor #Medical Devices newswire.ca

Site	Largest	Latest
Edmonton, Canada	$138.0M	2025-03-11

Investors

Loading…